Merck drug shines at ASCO
June 4, 2014Research and Development, Sales and Marketing ASCO, Cancer, FDA, MK-3475, Merck, melanoma
Merck has shown off one of its investigative cancer drug’s impressive results in advanced head and neck cancer at ASCO …
Health select committee chairman resigns
June 3, 2014Medical Communications, Sales and Marketing Conservative, NHS, Stephen Dorrell, health secretary, lankly, reforms
The Conservative MP for Charnwood Stephen Dorrell who has chaired the health select committee since 2010, has resigned. The unexpected …
China manufacturing slips in May
June 3, 2014Manufacturing and Production China, hsbc, manufacturing, pmi
Activity in China’s manufacturing sector slipped slightly in May, according to figures from HSBC, with the bank suggesting that the …
Novartis hires Merck president to lead oncology
June 3, 2014Medical Communications, Research and Development, Sales and Marketing Bruno Strigini, MSD, Merck, Novartis, oncology
Novartis has hired Merck’s president of Europe and Canada Bruno Strigini to be its president of oncology. The role was …
Boehringer lung cancer drug shows survival benefit
June 3, 2014Sales and Marketing ASCO, Boehringer, NSCLC, afatinib, giotrif, lung cancer
A new analysis of two late-stage trials shows that Boehringer drug Giotrif extends overall survival in a large proportion of …
GSK signs Adaptimmune deal
June 3, 2014Manufacturing and Production, Research and Development, Sales and Marketing AZ, Adaptimmune, BMS, Cancer, GSK, oncology
GlaxoSmithKline has signed a deal to develop and commercialise biotech firm Adaptimmune’s lead clinical cancer programme with T-cell receptors (TCRs), …
Patricell appoints business development specialist
June 3, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing patricell, robertshaw
Nottingham-based life sciences supplier firm Patricell has appointed an experienced business development manager in Lucy Robertshaw. Robertshaw has years of …
Cialis OTC approval sought
June 2, 2014Sales and Marketing Cialis, ED, OTC, Sanofi, lilly
Sanofi and Eli Lilly have announced they are to push ahead with plans to seek regulatory approval for erectile dysfunction …
Lemtrada resubmitted to FDA
June 2, 2014Sales and Marketing FDA, Lemtrada, MS, Sanofi
Sanofi has resubmitted its application for Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis (MS) to the …
Masters Speciality Pharma hires two
June 2, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing masters, mosa, rosetti
UK-based pharma supply firm Masters Speciality Pharma has made two new key appointments to strengthen its team. Ivan Rosetti (pictured) …
David Haslam: NICE, drug pricing and ethics
June 2, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chairman, Dillon, NHS, NICE, adams, has lam
Since 2010, I have spent a great deal of time of writing about NICE, covering nearly all of all its …
ASCO 2014: old dogs, new tricks top the bill
June 2, 2014Research and Development, Sales and Marketing ASCO, Cancer, chicago, docetaxel, exemestane
Research showing the effectiveness of established cancer treatments in new settings is taking centre stage at this year’s American Society …
Italy eyes €1.2 billion pharma fine
May 30, 2014Sales and Marketing Novartis, Roche, avastin, off label, wet and
Italy’s health ministry says it is looking for €1.2 billion in damages from Roche and Novartis over claims that the …
Pharma still lagging behind docs and patients in digital
May 30, 2014Medical Communications, Sales and Marketing digital, eye for pharma, marketing, multichannel
The pharma industry is still struggling with multichannel marketing which is putting it out of sync with patients and doctors, …
GSK pondering £7.5 billion drugs sale
May 30, 2014Sales and Marketing GSK, Paxil, ageing, drugs, established, imitrex, zofran
GlaxoSmithKline is looking to make more than £7 billion by selling off its ageing portfolio of established drugs. This is …
IT director Chris Roche joins Aridhia
May 30, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMC, IT, Roche, aridhia
Health tech informatics firm Aridhia has appointed Chris Roche to a newly-created post on its executive team as chief commercial …
BMJ slams EMA ‘U-turn’
May 30, 2014Medical Communications, Research and Development, Sales and Marketing BMJ, EMA, alltrials, data, transparency
The BMJ has attacked the European Medicines Agency for what it believes is a decision to ‘backtrack’ on public access …
£47.5 million fund for UK life sciences
May 29, 2014Research and Development, Sales and Marketing European Investment Fund, Scottish Enterprise, Strathclyde Pension Fund, UK, epidarex, life sciences, lilly
A new fund has raised more than £47.5 million to help set up early-stage life science and health technology companies …
Samsung health platform launched
May 29, 2014Medical Communications, Sales and Marketing Apple, Samsung, heathtech, iwatch, smart band, wearable
Samsung has taken another step towards realising the potential of wearable health tech with the launch of a new ‘smart’ …
Boehringer settles US lawsuits
May 29, 2014Medical Communications, Sales and Marketing Boehringer, Pradaxa, US, blood, lawsuits, warfarin
Boehringer Ingelheim has sought to bring to an end around 4,000 legal cases which have been brought against the company …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
